3billion

3billion 3billion provides genetic testing service for patients with rare diseases. We'll keep you updated wi

26/08/2026

𝐆𝐄𝐁𝐑𝐀 𝐢𝐬 𝐧𝐨𝐰 𝐨𝐩𝐞𝐧 𝐭𝐨 𝐞𝐱𝐩𝐥𝐨𝐫𝐞. 👀

You can now 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐭𝐡𝐞 𝐆𝐄𝐁𝐑𝐀 𝐰𝐨𝐫𝐤𝐟𝐥𝐨𝐰 𝐛𝐞𝐟𝐨𝐫𝐞 𝐬𝐢𝐠𝐧𝐢𝐧𝐠 𝐮𝐩—from prioritized variant review and clinical evidence to report generation.

Want to go further?

Sign up, upload your own VCF, and try the workflow with your own data.

𝐍𝐨 𝐝𝐞𝐦𝐨 𝐫𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐢𝐫𝐬𝐭. 𝐍𝐨 𝐬𝐚𝐥𝐞𝐬 𝐦𝐞𝐞𝐭𝐢𝐧𝐠 𝐫𝐞𝐪𝐮𝐢𝐫𝐞𝐝 𝐣𝐮𝐬𝐭 𝐭𝐨 𝐭𝐚𝐤𝐞 𝐚 𝐥𝐨𝐨𝐤.

Explore GEBRA first. Try it with your own data next.

🔗 𝐓𝐫𝐲 𝐆𝐄𝐁𝐑𝐀 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐢𝐧 𝐨𝐮𝐫 𝐒𝐭𝐨𝐫𝐲.

24/08/2026

✈️ 𝐎𝐧𝐞 𝐝𝐨𝐨𝐫 𝐥𝐚𝐭𝐞𝐫… 𝐡𝐞𝐥𝐥𝐨, 𝐇𝐞𝐥𝐬𝐢𝐧𝐤𝐢!
Our team is heading from 3billion in Korea to 𝐒𝐒𝐈𝐄𝐌 2026!

We’re on our way to Helsinki to connect with the metabolic disease community and share how 3billion is supporting rare disease diagnosis through genetic testing. 🧬

Going to SSIEM 2026 too?
Come find us at 𝐁𝐨𝐨𝐭𝐡 — we’d love to say hello! 👋

See you in Helsinki✨

📍 𝐋𝐨𝐜𝐚𝐭𝐢𝐨𝐧: Messukeskus / Helsinki, Finland
🏷️ 𝐓𝐚𝐠:

🧬 𝗠𝗲𝗮𝗻𝗶𝗻𝗴𝗳𝘂𝗹 𝗺𝗼𝗺𝗲𝗻𝘁𝘀 𝗮𝘁 𝗦𝗘𝗔-𝗠𝗶𝗡𝗗 𝟮𝟬𝟮𝟲.Thank you to everyone who stopped by the 3billion booth and shared insights with u...
06/07/2026

🧬 𝗠𝗲𝗮𝗻𝗶𝗻𝗴𝗳𝘂𝗹 𝗺𝗼𝗺𝗲𝗻𝘁𝘀 𝗮𝘁 𝗦𝗘𝗔-𝗠𝗶𝗡𝗗 𝟮𝟬𝟮𝟲.

Thank you to everyone who stopped by the 3billion booth and shared insights with us.

We were glad to connect with the movement disorders community and discuss how genetic testing can support earlier, more accurate diagnoses.

📍 Penang, Malaysia

See you at the next event! 👋

3𝐁-𝐍𝐄𝐎: 𝐓𝐡𝐞 𝐍𝐞𝐱𝐭 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐍𝐞𝐰𝐛𝐨𝐫𝐧 𝐂𝐚𝐫𝐞 𝐇𝐚𝐬 𝐀𝐫𝐫𝐢𝐯𝐞𝐝.  🚀We are thrilled to officially launch 3𝐁-𝐍𝐄𝐎—a premium genomic...
04/06/2026

3𝐁-𝐍𝐄𝐎: 𝐓𝐡𝐞 𝐍𝐞𝐱𝐭 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐍𝐞𝐰𝐛𝐨𝐫𝐧 𝐂𝐚𝐫𝐞 𝐇𝐚𝐬 𝐀𝐫𝐫𝐢𝐯𝐞𝐝. 🚀

We are thrilled to officially launch 3𝐁-𝐍𝐄𝐎—a premium genomic newborn screening option designed to seamlessly complement traditional NBS.

By leveraging advanced Whole Exome (WES) and Whole Genome (WGS) sequencing, 3B-NEO analyzes 595 genes associated with serious, actionable pediatric-onset conditions. It provides stable, lifelong genetic insights directly from DNA —without adding any operational burden to your institution.

👉 Learn more about 3B-NEO:
For clinicians: https://3billion.io/neo
For moms: https://neo.3billion.io/info

May is EDS Awareness Month! 🦓3billion supports the EDS community, including patients and their families. To spread aware...
19/05/2026

May is EDS Awareness Month! 🦓

3billion supports the EDS community, including patients and their families. To spread awareness, we want to highlight the importance of Ehlers-Danlos Syndromes (EDS).

We hope this month serves as a meaningful opportunity to keep EDS in mind for your practice.
Together, we can make a difference.

Most-Popular Report of 2025?Rare disease diagnosis is advancing — but not evenly.The 2025 Global Rare Disease Diagnostic...
31/12/2025

Most-Popular Report of 2025?

Rare disease diagnosis is advancing — but not evenly.
The 2025 Global Rare Disease Diagnostics Report became our most-popular report because it captured what clinicians are really experiencing across healthcare systems worldwide: progress, delays, trade-offs, and gaps between what’s possible and what’s accessible.

Visibility is often the first step toward change.

👉 Curious how other doctors are dealing with?
Get the full picture of the rare disease landscape.
Comment “Report” and we’ll DM you the download link.

Most-Viewed Webinar of 2025?Variants of Uncertain Significance (VUS) live in the gray zone — and clinicians live with th...
30/12/2025

Most-Viewed Webinar of 2025?

Variants of Uncertain Significance (VUS) live in the gray zone — and clinicians live with that uncertainty every day.
Our most-viewed on-demand webinar of 2025 brought experts from Asia and Europe together to talk about something rarely discussed openly: how VUS is actually handled in real clinical practice.
Because uncertainty isn’t the end of the journey — it’s part of it.

Ready to navigate the gray zone? Comment “VUS” and we’ll send you the on-demand webinar link in your DM.

Most-Viewed Webinar of 2025?Variants of Uncertain Significance (VUS) live in the gray zone — and clinicians live with th...
29/12/2025

Most-Viewed Webinar of 2025?

Variants of Uncertain Significance (VUS) live in the gray zone — and clinicians live with that uncertainty every day.
Our most-viewed on-demand webinar of 2025 brought experts from Asia and Europe together to talk about something rarely discussed openly: how VUS is actually handled in real clinical practice.
Because uncertainty isn’t the end of the journey — it’s part of it.

Want to read the full post? Comment “Cost” and we’ll send the link directly to your DM!

Happy Holidays! 🎄As 2025 comes to a close, all of us at 3billion want to express our deepest gratitude for your support ...
25/12/2025

Happy Holidays! 🎄

As 2025 comes to a close, all of us at 3billion want to express our deepest gratitude for your support and partnership this year. We are honored to be part of your clinical journey.

Wishing you a peaceful and restful end to the year. ✨

Most-Downloaded Clinical Intelligence of 2025?In a year full of data, clinicians consistently turned to one starting poi...
24/12/2025

Most-Downloaded Clinical Intelligence of 2025?

In a year full of data, clinicians consistently turned to one starting point: patient symptoms.

Our most-downloaded clinical intelligence resources in 2025 were “Top Symptoms by Region” — connecting real-world presentations to positive WES and WGS outcomes across regions.
It’s a reminder that good diagnostics still start where clinicians always begin: with what they see.

👉 Want to explore the regional data?
Comment ‘Link’ below, and we’ll send the direct links to all sheets via your DM.

#2025

Address

강남구 테헤란로 416, 13층/14층
Seoul
06193

Opening Hours

Monday 09:00 - 18:00
Tuesday 09:00 - 18:00
Wednesday 09:00 - 18:00
Thursday 09:00 - 18:00
Friday 09:00 - 18:00

Alerts

Be the first to know and let us send you an email when 3billion posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to 3billion:

Shortcuts

Share